How Supplements Are Regulated: DSHEA 1994 vs Prescription Drug Approvals

Understanding FDA oversight of dietary supplements: pre-market vs post-market regulation, cGMP audits, and structure-function claims.

The Fundamental Difference: Food vs Pharmaceutical Drugs

Prescription drugs require multi-phase clinical human trials and formal pre-market FDA approval before they can be prescribed. Under the Dietary Supplement Health and Education Act (DSHEA 1994), dietary supplements are regulated as specialized foods, meaning no pre-market approval is granted by the FDA.

What FDA cGMP Facility Registration Actually Means

While the FDA does not 'approve' individual supplement formulas, it enforces stringent regulatory oversight over manufacturing facilities under 21 CFR Part 111. Facilities producing {C.BRAND} must maintain cGMP certification, requiring documented raw material identity testing, batch uniformity, and sanitation protocols.

Structure-Function Claims vs Disease Claims

Federal law permits supplements to describe how nutrients support normal physiological functions (e.g., 'supports healthy glucose metabolism' or 'supports steady energy'). However, supplements are strictly prohibited from claiming to treat or cure diseases (e.g., 'cures diabetes').

Post-Market Surveillance and Adverse Event Reporting

The FDA monitors supplement safety post-market through mandatory Adverse Event Reporting (AER) systems and conducts unannounced facility inspections, issuing warning letters or recalling products that fail identity or safety standards.